Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-1|1|238|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-2|1|363|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-3|1|435|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-4|1|467|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-5|1|471|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-6|1|477|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-7|1|493|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-8|1|512|Neoplasia malignant|Lower respiratory system|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-9|1|602|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-10|1|606|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-11|1|634|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-12|1|636|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-13|1|650|Neoplasia malignant|Lower respiratory system|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-14|1|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-15|1|672|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-16|1|673|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-17|1|677|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-18|1|705|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-19|1|719|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-20|1|728|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-21|1|744|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-22|1|746|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-23|1|748|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-24|1|756|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-25|1|764|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-26|1|764|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-27|1|766|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-28|1|768|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-29|1|771|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-30|1|783|Neoplasia malignant|Lower respiratory system|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-31|1|785|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-32|1|792|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-33|1|793|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-34|1|800|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-35|1|801|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-36|1|802|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-37|1|806|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-38|1|808|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-39|1|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-40|1|816|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-41|1|819|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-42|1|828|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-43|1|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-44|1|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-45|1|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-46|1|869|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-47|1|869|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-48|1|876|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-49|1|876|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-50|1|876|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-51|1|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-52|1|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-53|1|880|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-54|1|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-55|1|889|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-56|1|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-57|1|894|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-58|1|904|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-59|1|913|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-60|1|921|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-61|1|921|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-62|1|927|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-63|1|930|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-64|1|932|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-65|1|934|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-66|1|952|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-67|1|952|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-68|1|958|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-69|1|965|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-70|1|965|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-71|1|966|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-72|1|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-73|1|968|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-74|1|971|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-75|1|971|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-76|1|973|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-77|1|984|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-78|1|986|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-79|1|987|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-80|1|993|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-81|1|995|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-82|1|1003|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-83|1|1004|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-84|1|1004|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-85|1|1006|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-86|1|1008|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-87|1|1012|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-88|1|1020|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-89|1|1021|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-90|1|1022|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-91|1|1024|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-92|1|1032|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-93|1|1033|Neoplasia benign|Lower respiratory system|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-94|1|1042|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-95|1|1042|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-96|1|1042|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-97|1|1043|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-98|1|1054|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-99|1|1055|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-100|1|1065|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-101|1|1065|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-102|1|1081|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-103|1|1082|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-104|1|1090|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-105|1|1090|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-106|1|1092|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-107|1|1105|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-108|1|1123|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-109|1|1151|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-110|1|1154|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-111|1|1159|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-112|1|1169|Neoplasia benign|Lower respiratory system|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-113|1|1173|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-114|1|1173|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-115|1|1176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-116|1|1192|Other deterministic changes|Whole body|n/a|
10-5-1|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|117 (117 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|342 offspring from 53 litters from 60 dams|10-5-1-117|1|1208|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-1|2|346|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-2|2|415|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-3|2|434|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-4|2|437|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-5|2|484|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-6|2|493|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-7|2|499|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-8|2|550|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-9|2|608|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-10|2|625|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-11|2|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-12|2|664|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-13|2|668|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-14|2|669|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-15|2|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-16|2|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-17|2|672|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-18|2|674|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-19|2|680|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-20|2|689|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-21|2|692|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-22|2|699|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-23|2|699|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-24|2|702|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-25|2|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-26|2|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-27|2|715|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-28|2|735|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-29|2|736|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-30|2|737|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-31|2|738|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-32|2|738|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-33|2|744|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-34|2|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-35|2|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-36|2|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-37|2|779|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-38|2|781|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-39|2|785|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-40|2|847|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-41|2|848|Neoplasia malignant|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-42|2|852|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-43|2|856|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-44|2|863|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-45|2|867|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-46|2|871|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-47|2|872|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-48|2|876|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-49|2|876|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-50|2|877|Neoplasia malignant|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-51|2|878|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-52|2|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-53|2|880|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-54|2|881|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-55|2|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-56|2|900|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-57|2|904|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-58|2|911|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-59|2|911|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-60|2|914|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-61|2|920|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-62|2|920|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-63|2|921|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-64|2|926|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-65|2|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-66|2|931|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-67|2|931|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-68|2|932|Neoplasia benign|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 270 - adenoma|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-69|2|934|Neoplasia benign|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-70|2|934|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-71|2|946|Neoplasia benign|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-72|2|964|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-73|2|967|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-74|2|977|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-75|2|983|Neoplasia malignant|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-76|2|985|Neoplasia malignant|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-77|2|991|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-78|2|994|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-79|2|1001|Neoplasia benign|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-80|2|1001|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-81|2|1002|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-82|2|1009|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-83|2|1012|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-84|2|1017|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-85|2|1018|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-86|2|1023|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-87|2|1044|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-88|2|1055|Neoplasia malignant|Lower respiratory system|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-89|2|1057|Neoplasia benign|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 270 - adenoma|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-90|2|1068|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-91|2|1068|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-92|2|1077|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-93|2|1078|Other deterministic changes|Whole body|n/a|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-94|2|1086|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-2|LTSC,n/a|1|n/a|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|95 (95 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|342 offspring from 53 litters from 60 dams|10-5-2-95|2|1097|Neoplasia malignant|Lower respiratory system|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-1|3|380|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-2|3|391|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-3|3|509|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-4|3|547|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-5|3|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-6|3|554|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-7|3|556|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-8|3|569|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-9|3|600|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-10|3|630|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-11|3|647|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-12|3|664|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-13|3|686|Neoplasia malignant|Lower respiratory system|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-14|3|703|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-15|3|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-16|3|745|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-17|3|771|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-18|3|776|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-19|3|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-20|3|807|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-21|3|811|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-22|3|813|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-23|3|813|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-24|3|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-25|3|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-26|3|820|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-27|3|846|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-28|3|847|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-29|3|854|Neoplasia malignant|Lower respiratory system|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-30|3|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-31|3|859|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-32|3|868|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-33|3|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-34|3|873|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-35|3|880|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-36|3|881|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-37|3|882|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-38|3|896|Neoplasia malignant|Lower respiratory system|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-39|3|909|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-40|3|926|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-41|3|948|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-42|3|952|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-43|3|960|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-44|3|965|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-45|3|966|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-46|3|970|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-47|3|971|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-48|3|977|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-49|3|987|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-50|3|994|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-51|3|998|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-52|3|998|Neoplasia malignant|Lower respiratory system|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-53|3|1000|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-54|3|1012|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-55|3|1032|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 218 - neoplasm|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-56|3|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-57|3|1049|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-58|3|1050|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-59|3|1058|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-60|3|1058|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-61|3|1065|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-62|3|1071|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-63|3|1071|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-64|3|1080|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-65|3|1086|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-66|3|1115|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-67|3|1119|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-68|3|1121|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-69|3|1166|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-70|3|1183|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-71|3|1184|Other deterministic changes|Whole body|n/a|
10-5-3|LTo,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|72 (72 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|200 offspring from 32 litters from 46 dams|10-5-3-72|3|1191|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-1|4|295|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-2|4|426|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-3|4|449|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-4|4|530|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-5|4|545|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-6|4|547|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-7|4|548|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-8|4|552|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-9|4|561|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-10|4|604|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-11|4|619|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-12|4|630|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-13|4|646|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-14|4|647|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-15|4|658|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-16|4|664|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-17|4|673|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-18|4|673|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-19|4|678|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-20|4|681|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-21|4|692|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-22|4|694|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-23|4|713|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-24|4|716|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-25|4|726|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-26|4|749|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-27|4|755|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-28|4|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-29|4|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-30|4|785|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-31|4|799|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-32|4|813|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-33|4|835|Neoplasia malignant|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-34|4|842|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-35|4|843|Neoplasia malignant|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-36|4|857|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-37|4|879|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-38|4|889|Neoplasia benign|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-39|4|894|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-40|4|902|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-41|4|925|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-42|4|936|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-43|4|941|Neoplasia benign|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-44|4|941|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-45|4|942|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-46|4|955|Neoplasia benign|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-47|4|955|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-48|4|956|Neoplasia malignant|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-49|4|966|Neoplasia malignant|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-50|4|967|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-51|4|981|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-52|4|982|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-53|4|998|Neoplasia benign|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-54|4|1001|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-55|4|1002|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-56|4|1002|Neoplasia benign|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-57|4|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-58|4|1007|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-59|4|1016|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-60|4|1055|Neoplasia benign|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-61|4|1060|Other deterministic changes|Whole body|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-62|4|1135|Neoplasia malignant|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-63|4|1142|Neoplasia malignant|Lower respiratory system|n/a|
10-5-4|Lto,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|64 (64 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|200 offspring from 32 litters from 46 dams|10-5-4-64|4|1160|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-1|5|527|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-2|5|532|Neoplasia malignant|Lower respiratory system|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-3|5|532|Neoplasia malignant|Lower respiratory system|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-4|5|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-5|5|591|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-6|5|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-7|5|676|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-8|5|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-9|5|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-10|5|718|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-11|5|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-12|5|751|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-13|5|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-14|5|768|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-15|5|769|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-16|5|772|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-17|5|772|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-18|5|782|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-19|5|814|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-20|5|824|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-21|5|840|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-22|5|854|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-23|5|876|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-24|5|880|Neoplasia benign|Lower respiratory system|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-25|5|890|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-26|5|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-27|5|907|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-28|5|910|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-29|5|910|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-30|5|910|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-31|5|914|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-32|5|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-33|5|914|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-34|5|927|Neoplasia malignant|Lower respiratory system|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-35|5|927|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-36|5|938|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-37|5|940|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-38|5|941|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-39|5|945|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-40|5|947|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-41|5|975|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-42|5|975|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-43|5|985|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-44|5|1001|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-45|5|1010|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-46|5|1011|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-47|5|1013|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-48|5|1023|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-49|5|1037|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-50|5|1053|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-51|5|1053|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-52|5|1096|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-53|5|1097|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-54|5|1099|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-55|5|1108|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-56|5|1122|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-57|5|1130|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-58|5|1130|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-59|5|1135|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-60|5|1142|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-61|5|1145|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-62|5|1159|Neoplasia benign|Lower respiratory system|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-63|5|1163|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-64|5|1171|Other deterministic changes|Whole body|n/a|
10-5-5|LT1,n/a|1|-22|Pu-239 citrate|10|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 10.0   0.14 range 7.9-12.1|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|306 offspring from 42 litters from 46 dams|10-5-5-65|5|1184|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-1|6|234|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-2|6|335|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-3|6|383|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-4|6|431|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-5|6|494|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-6|6|496|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-7|6|500|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-8|6|507|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-9|6|533|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-10|6|534|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-11|6|548|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-12|6|581|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-13|6|589|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-14|6|603|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-15|6|610|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-16|6|613|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-17|6|620|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-18|6|622|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-19|6|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-20|6|637|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-21|6|695|Neoplasia benign|Lower respiratory system|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-22|6|705|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-23|6|711|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-24|6|723|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-25|6|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-26|6|736|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-27|6|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-28|6|743|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-29|6|746|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-30|6|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-31|6|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-32|6|758|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-33|6|760|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-34|6|768|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-35|6|771|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-36|6|772|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-37|6|772|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-38|6|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-39|6|796|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-40|6|800|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-41|6|800|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-42|6|808|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-43|6|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-44|6|827|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-45|6|830|Neoplasia malignant|Lower respiratory system|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-46|6|869|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-47|6|872|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-48|6|872|Neoplasia benign|Lower respiratory system|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-49|6|899|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-50|6|925|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-51|6|932|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-52|6|945|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-53|6|952|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-54|6|952|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-55|6|956|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-56|6|956|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-57|6|967|Neoplasia malignant|Lower respiratory system|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-58|6|973|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-59|6|973|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-60|6|981|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-61|6|991|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-62|6|1019|Neoplasia benign|Lower respiratory system|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-63|6|1075|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-64|6|1102|Other deterministic changes|Whole body|n/a|
10-5-6|LT1,n/a|1|-22|none (controls)|0|unit code not relevant|Injection, intraperitoneal|Infusion control|65 (65 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|306 offspring from 42 litters from 46 dams|10-5-6-65|6|1108|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-1|7|462|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-2|7|680|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-3|7|713|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-4|7|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-5|7|767|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-6|7|843|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-7|7|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-8|7|848|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-9|7|874|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-10|7|876|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-11|7|877|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-12|7|877|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-13|7|890|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-14|7|899|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-15|7|899|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-16|7|935|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-17|7|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-18|7|967|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-19|7|1007|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-20|7|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-21|7|1037|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-22|7|1064|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-23|7|1064|Neoplasia benign|Lower respiratory system|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-24|7|1064|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-25|7|1092|Neoplasia malignant|Lower respiratory system|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-26|7|1102|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-27|7|1123|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-28|7|1127|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-29|7|1141|Other deterministic changes|Whole body|n/a|
10-5-7|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|30 (30 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|186 offspring from 34 litters from 46 dams|10-5-7-30|7|1163|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-1|8|528|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-2|8|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-3|8|532|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-4|8|556|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-5|8|556|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-6|8|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-7|8|626|Neoplasia malignant|Lower respiratory system|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-8|8|646|Neoplasia benign|Lower respiratory system|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-9|8|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-10|8|697|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-11|8|697|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-12|8|701|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-13|8|715|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-14|8|716|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-15|8|727|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-16|8|743|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-17|8|763|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-18|8|776|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-19|8|791|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-20|8|800|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-21|8|812|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-22|8|820|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-23|8|820|Neoplasia malignant|Lower respiratory system|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-24|8|843|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-25|8|871|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-26|8|892|Neoplasia malignant|Lower respiratory system|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-27|8|896|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-28|8|896|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-29|8|900|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-30|8|920|Other deterministic changes|Whole body|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-31|8|925|Neoplasia benign|Lower respiratory system|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-32|8|935|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-33|8|983|Neoplasia malignant|Lower respiratory system|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-34|8|989|Neoplasia malignant|Lower respiratory system|n/a|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-35|8|1022|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-8|LT2,n/a|1|-22|Pu-239 citrate|20|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 20.0   0.35 range 12.6-23.9|36 (36 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|186 offspring from 34 litters from 46 dams|10-5-8-36|8|1023|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-1|9|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-2|9|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-3|9|543|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-4|9|544|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-5|9|554|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-6|9|571|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-7|9|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-8|9|582|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-9|9|608|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-10|9|647|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-11|9|648|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-12|9|655|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-13|9|668|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-14|9|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-15|9|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-16|9|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-17|9|730|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-18|9|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-19|9|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-20|9|765|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-21|9|765|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-22|9|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-23|9|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-24|9|788|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-25|9|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-26|9|799|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-27|9|815|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-28|9|825|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-29|9|825|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-30|9|839|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-31|9|840|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-32|9|847|Neoplasia malignant|Lower respiratory system|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-33|9|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-34|9|854|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-35|9|862|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-36|9|869|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-37|9|890|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-38|9|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-39|9|899|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-40|9|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-41|9|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-42|9|926|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-43|9|926|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-44|9|927|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-45|9|933|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-46|9|938|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-47|9|947|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-48|9|947|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-49|9|956|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-50|9|958|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-51|9|970|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-52|9|977|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-53|9|982|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-54|9|983|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-55|9|984|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-56|9|984|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-57|9|986|Neoplasia malignant|Lower respiratory system|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-58|9|993|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-59|9|1006|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-60|9|1007|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-61|9|1015|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-62|9|1020|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-63|9|1022|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-64|9|1024|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-65|9|1024|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-66|9|1059|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-67|9|1078|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 218 - neoplasm|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-68|9|1091|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-69|9|1102|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-70|9|1115|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-71|9|1129|Neoplasia malignant|Lower respiratory system|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-72|9|1144|Other deterministic changes|Whole body|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-73|9|1151|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-9|Lt3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|74 (74 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-9-74|9|1162|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-1|10|451|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-2|10|527|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-3|10|540|Neoplasia malignant|Lower respiratory system|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-4|10|542|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-5|10|569|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-6|10|619|Neoplasia malignant|Lower respiratory system|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-7|10|626|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-8|10|653|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-9|10|664|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-10|10|681|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-11|10|688|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-12|10|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-13|10|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-14|10|699|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-15|10|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-16|10|727|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-17|10|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-18|10|742|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-19|10|746|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-20|10|750|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-21|10|799|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-22|10|799|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-23|10|800|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-24|10|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-25|10|815|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-26|10|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-27|10|820|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-28|10|826|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-29|10|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-30|10|836|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-31|10|836|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-32|10|848|Neoplasia malignant|Lower respiratory system|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-33|10|848|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-34|10|854|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-35|10|859|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-36|10|864|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-37|10|875|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-38|10|881|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-39|10|883|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-40|10|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-41|10|906|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-42|10|909|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-43|10|923|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-44|10|924|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-45|10|934|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-46|10|937|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-47|10|938|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-48|10|955|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-49|10|961|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-50|10|962|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-51|10|969|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-52|10|977|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-53|10|983|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-54|10|983|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-55|10|988|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-56|10|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-57|10|1010|Other deterministic changes|Whole body|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-58|10|1010|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-59|10|1010|Neoplasia malignant|Lower respiratory system|n/a|
10-5-10|LT3,n/a|1|-22|Pu-239 citrate|38|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 38.0   0.97 range 19.2-47.2|60 (60 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|210 offspring fom 33 litters from 42 dams|10-5-10-60|10|1035|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-1|11|345|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-2|11|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-3|11|490|Neoplasia malignant|Lower respiratory system|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-4|11|617|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-5|11|638|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-6|11|697|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-7|11|707|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-8|11|756|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-9|11|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-10|11|770|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-11|11|772|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-12|11|776|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-13|11|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-14|11|792|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-15|11|796|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-16|11|853|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-17|11|889|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-18|11|896|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-19|11|903|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-20|11|917|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-21|11|917|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-22|11|919|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-23|11|924|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-24|11|942|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-25|11|945|Neoplasia malignant|Lower respiratory system|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-26|11|969|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 218 - neoplasm|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-27|11|972|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-28|11|973|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-29|11|981|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-30|11|993|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-31|11|1006|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-32|11|1012|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-33|11|1028|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-34|11|1041|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-35|11|1072|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-36|11|1082|Neoplasia benign|Lower respiratory system|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-37|11|1099|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-38|11|1128|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-39|11|1143|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-40|11|1165|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-41|11|1173|Other deterministic changes|Whole body|n/a|
10-5-11|Lt4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|42 (42 in ERA)|Mouse|Mouse, CBA/CA|Female|Prenatal|148 offspring from 25 litters from 28 dams|10-5-11-42|11|1177|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-1|12|351|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-2|12|460|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-3|12|498|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-4|12|529|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-5|12|611|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-6|12|611|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-7|12|612|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-8|12|646|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-9|12|667|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-10|12|688|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-11|12|692|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-12|12|709|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-13|12|728|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-14|12|735|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-15|12|737|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-16|12|772|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-17|12|772|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-18|12|800|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-19|12|812|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-20|12|815|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-21|12|834|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-22|12|849|Neoplasia malignant|Lower respiratory system|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-23|12|855|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-24|12|873|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-25|12|876|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-26|12|891|Neoplasia malignant|Lower respiratory system|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-27|12|915|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-28|12|933|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-29|12|946|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-30|12|948|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-31|12|959|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-32|12|989|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-33|12|999|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-34|12|1002|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-35|12|1004|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-36|12|1017|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-37|12|1025|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-38|12|1026|Neoplasia malignant|Lower respiratory system|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-39|12|1035|Neoplasia benign|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 270 - adenoma|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-40|12|1040|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-41|12|1070|Neoplasia benign|Lower respiratory system|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-42|12|1072|Neoplasia benign|Lower respiratory system|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-43|12|1096|Other deterministic changes|Whole body|n/a|
10-5-12|LT4,n/a|1|-22|Pu-239 citrate|83|kilobecquerels per kilogram animal|Injection, intraperitoneal|infused entire pregnancy 83.0   1.74 range 57.2-97.3|44 (44 in ERA)|Mouse|Mouse, CBA/CA|Male|Prenatal|48 offspring from 25 litters from 28 dams|10-5-12-44|12|1125|Other deterministic changes|Whole body|n/a|
